Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3.

European journal of clinical investigation·2005
Same author

New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.

Clinical nephrology·2005
Same author

Should we biopsy kidneys of patients post-liver transplant?

Transplantation proceedings·2003
Same author

Stimulation of osteoclastic bone resorption in a model of glycerol-induced acute renal failure: evidence for a parathyroid hormone-independent mechanism.

Bone·2002
Same author

Segmental localization of mRNAs encoding Na(+)-K(+)-ATPase alpha(1)- and beta(1)-subunits in diabetic rat kidneys using RT-PCR.

American journal of physiology. Renal physiology·2002
Same author

Vitamin D reduces renal NaPi-2 in PTH-infused rats: complexity of vitamin D action on renal P(i) handling.

American journal of physiology. Renal physiology·2001

相关实验视频

Updated: Jul 10, 2026

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

二次性甲状腺功能障碍. 副甲状腺功能障碍. 在患有功能衰竭的患者中进行保守的治疗.

M M Popovtzer, W F Pinggera, J B Robinette

    JAMA
    |March 3, 1975
    PubMed
    概括
    此摘要是机器生成的。

    酸结合抗酸剂和碳酸有效地管理了晚期病患者的二次性甲状腺功能障碍. 这种治疗使副甲状腺激素水平正常化,并解决了相关症状和骨疾病.

    更多相关视频

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
    04:36

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

    Published on: April 14, 2026

    相关实验视频

    Last Updated: Jul 10, 2026

    Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
    09:46

    Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

    Published on: February 16, 2024

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
    04:36

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

    Published on: April 14, 2026

    科学领域:

    • 腎臟病學 (nephrology) 是一種醫學專業.
    • 内分泌学 在内分泌学.
    • 矿物质的新陈代谢.

    背景情况:

    • 晚期脏疾病往往导致二次性甲状腺功能障碍.
    • 系统性表现包括骨疾病和荷尔蒙失衡.

    研究的目的:

    • 评估酸盐结合剂和口服碳酸在治疗二次性甲状腺功能障碍症中的有效性.
    • 评估对血清,,副甲状腺激素和临床症状的影响.

    主要方法:

    • 治疗3名患有晚期病的患者 (胰岛素清除率4.6-9.1毫升/分钟).
    • 使用酸结合抗酸剂和口服碳酸.
    • 监测血清,和免疫反应性副甲状腺激素水平.

    主要成果:

    • 血清和水平保持在正常范围内.
    • 二次性甲状腺功能障碍症症状的逐渐消失.
    • 观察到骨质炎纤维化的愈合.
    • 血清免疫性甲状腺激素度的正常化.

    结论:

    • 酸结合抗酸剂和口服碳酸在治疗晚期病的二次性甲状腺功能障碍时是有效的.
    • 这种治疗方法可以导致症状缓解和生化正常化.
    • 证明了成功治疗纤维性骨炎.